drugset / Trial / NCT00399477
A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Patients with Parkinson's Disease (PD) will be divided into 2 groups at each study center at their first visit based on the drugs they are taking for their PD: * Group 1 Patients using Azilect and no other therapy. * Group 2 Azilect in combination with other medications like Levodopa, Mirapex, or Requip.
Timeline
- Start
- 2006-10
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rasagiline | Small molecule | — | — |
| Background | Levodopa | Small molecule | — | — |
| Background | Pramipexole | Unknown | — | — |
| Background | Ropinirole | Small molecule | — | — |